Latest filing published 26 Jan 2024 for Touyun Biotech Group Ltd..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -50.0%Entry HK$1.08 · Close at T+365 HK$0.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chen Hui: trading record in brief
Chen Hui has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Touyun Biotech Group Ltd. and Quetta Acquisition Corp. Over a trading history stretching from 12 December 2017 to 11 October 2023, the count stands at 3 filings.
Market trades split into 2 purchases (€2.6M) and 1 sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: no purchases and 1 sale on the market.
The latest filing, published on 26 January 2024, reports an open-market sale in Touyun Biotech Group Ltd. The latest purchase dates back some time: it was published 1,123 days ago, on 13 October 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Chen Hui
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,250,000 sharesShareXHKGHKEX:DA20240126E00421
- 253,045 shares@ US$10.00100.0% of flowCommon StockSEC:0001829126-23-006619:0Canonical exit: 9 Jan 2024 (T+90)
- 5,000,000 shares@ HK$0.335100.0% of flowShareXHKGHKEX:DA20171215E00024Canonical exit: 12 Mar 2018 (T+90)
3 of 3 declarations